Submitted by Anonymous (not verified) on 10 July 2024 - 14:00
Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 5, Status: Authorised